🇺🇸 FDA
Patent

US 10780096

Pyrrolobenzodiazepine-antibody conjugates

granted A61KA61K31/5517A61K47/68035

Quick answer

US patent 10780096 (Pyrrolobenzodiazepine-antibody conjugates) held by ADC THERAPEUTICS SA expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ADC THERAPEUTICS SA
Grant date
Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K31/5517, A61K47/68035, A61K47/6849, A61K47/6889